Healthcare providers consistently work to decrease costs and improve outcomes. Assessing new products and technologies takes considerable time and effort, and requires engagement with both clinical and economic buyers. As a result, suppliers with new products that improve value and outcomes are often unknowingly excluded from consideration.
We help companies with leading-edge products, preparing them with tools and strategies required to be IDN and GPO-ready.
The ASPI leadership team is comprised of executives who were formerly with leading healthcare organizations including Boston Scientific, Medtronic, Johnson & Johnson, Vizient and Premier.
Our team has deep, varied and relevant functional expertise. We have owned and solved many of the challenges you face. We are committed to doing the same for you.